Jardy-Met 12.5/500mg Tablets combine Valsartan 12.5mg, an angiotensin receptor blocker (ARB), with Metformin 500mg, a biguanide antidiabetic agent, in a single fixed-dose tablet. This lower metformin dose formulation is designed for patients who are being introduced to combination therapy or those who experience gastrointestinal side effects at higher metformin doses. Valsartan controls blood pressure by blocking the renin-angiotensin-aldosterone system, while Metformin addresses hyperglycaemia through hepatic glucose suppression and improved peripheral insulin sensitivity.

The combination is particularly appropriate for patients who present with both Type 2 diabetes mellitus and hypertension — two conditions that often coexist and compound cardiovascular risk. Managing both with a single tablet improves compliance and simplifies the daily medication routine. The lower metformin dose (500mg) also allows gradual up-titration, minimising the risk of gastrointestinal intolerance. Renal function should be assessed before and periodically during treatment.

Common side effects include nausea, diarrhoea, headache, and dizziness. Hyperkalaemia may occur with ARB therapy — avoid concomitant potassium-sparing agents unless prescribed. A valid prescription is required. Do not stop taking Jardy-Met without consulting your doctor, and monitor blood pressure and blood glucose regularly as advised.

Order Jardy-Met 12.5/500mg from Derma.pk, delivering authentic anti-hypertensive and diabetes medicines across Pakistan. Submit your prescription to sales@derma.pk or WhatsApp +92-320-5999650.